Visceral leishmaniasis (VL) is a rare disease in renal transplant
recipients. Liposomal amphotericin B (AmBisome) is known to be effective
against VL. However,previously there has been no experience with
administration of such treatment to renal transplant recipients. We
report herein four patients with VL complicating renal transplantation
who were treated successfully with liposomal amphotericin B (total dose,
23-40 mg/kg). Neither adverse reactions nor clinical relapses of VL were
observed
